Prime Medicine, Inc. Common Stock (PRME) — Financial Flexibility Index
Prime Medicine, Inc. Common Stock (PRME) has a Financial Flexibility Index of -0.19x as of March 2026. Free cash flow of $-42.50 Million (operating CF $-42.71 Million minus capex $214.00K) represents 0% of total liabilities ($218.03 Million). Also explore Prime Medicine, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Prime Medicine, Inc. Common Stock Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Prime Medicine, Inc. Common Stock across 7 annual periods. Check PRME PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Prime Medicine, Inc. Common Stock (2019–2025)
Year-by-year free cash flow to debt coverage for Prime Medicine, Inc. Common Stock. For the full company profile including market capitalisation, see PRME market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.71x | $-158.03 Million | $-162.56 Million | $221.87 Million | ▲ +11.0% |
| 2024 | -0.80x | $-115.57 Million | $-122.86 Million | $144.36 Million | ▲ +68.9% |
| 2023 | -2.58x | $-156.69 Million | $-165.41 Million | $60.78 Million | ▲ +1.9% |
| 2022 | -2.63x | $-115.73 Million | $-131.83 Million | $44.04 Million | ▼ -446.9% |
| 2021 | -0.48x | $-29.93 Million | $-34.08 Million | $62.30 Million | ▼ -108.7% |
| 2020 | -0.23x | $-4.91 Million | $-5.54 Million | $21.31 Million | ▼ -142.0% |
| 2019 | -0.10x | $-695.00K | $-1.33 Million | $7.31 Million | — |